Arweave / HarryPotterTrumpSonic100Inu
0.0000957
17-February-25 02:10:13
realtime
Instruments
-4.0000000000001E-07
-0.42%
Today's range
0.0000942 - 0.0000981
ISIN
FXARBTC
Source
BINCE
-
Chart Industries, Inc. (NYSE:GTLS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
Kinder Morgan, Inc. (NYSE:KMI) Given Consensus Recommendation of "Moderate Buy" by Brokerages
17 Feb 2025 01:56:12 By Buzz FX
-
Verisk Analytics, Inc. (NASDAQ:VRSK) Given Consensus Recommendation of "Hold" by Brokerages
17 Feb 2025 01:56:12 By Buzz FX
-
Roth Capital Expects Stronger Earnings for Silvercorp Metals
17 Feb 2025 01:56:12 By Buzz FX
-
17 Feb 2025 01:56:12 By Buzz FX
-
DLocal Limited (NASDAQ:DLO) Receives Average Recommendation of "Hold" from Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
17 Feb 2025 01:56:12 By Buzz FX
-
Equinox Gold (EQX) to Release Quarterly Earnings on Wednesday
17 Feb 2025 01:56:12 By Buzz FX
-
Joby Aviation (JOBY) Expected to Announce Earnings on Wednesday
17 Feb 2025 01:56:12 By Buzz FX
-
Suncor Energy Inc. (TSE:SU) Receives Average Rating of "Moderate Buy" from Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
Southern Copper Co. (NYSE:SCCO) Given Average Rating of "Reduce" by Brokerages
17 Feb 2025 01:56:12 By Buzz FX
-
SAP SE (NYSE:SAP) Receives Consensus Recommendation of "Buy" from Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
17 Feb 2025 01:56:12 By Buzz FX
-
17 Feb 2025 01:56:12 By Buzz FX
-
Walmart Inc. (NYSE:WMT) Given Consensus Rating of "Moderate Buy" by Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
Allegiant Travel (NASDAQ:ALGT) Given Consensus Recommendation of "Hold" by Analysts
17 Feb 2025 01:56:12 By Buzz FX
-
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Consensus Rating of "Hold" from Brokerages
17 Feb 2025 01:56:12 By Buzz FX
-
Clearway Energy, Inc. (NYSE:CWEN) Given Average Recommendation of "Moderate Buy" by Brokerages
17 Feb 2025 01:56:12 By Buzz FX
-
Sunnova Energy International (NOVA) Expected to Announce Earnings on Wednesday
17 Feb 2025 01:56:12 By Buzz FX
-
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Rating of "Moderate Buy" from Brokerages
17 Feb 2025 01:56:12 By Buzz FX